Wang Lab
Wang Lab
The Wang lab is interested in developing drug leads/candidates for kinase, phosphate kinase and protein targets identified by UNC faculty and external investigators. We have successfully used the structure- and/or ligand-based drug design approaches to deliver compounds to clinic (MerTK inhibitors such as MRX-2843) or licensing (IDH1 inhibitor, co-developed with NCATs). We will continue to apply the similar approaches for drug discovery towards new targets.
Xiaodong Wang, PhD
Associate Professor, Chemical Biology and Medicinal Chemistry
Director of Medicinal Chemistry
xiaodonw@unc.edu
Ivie Conlon, PhD
Postdoc
iviecon@email.unc.edu
Shiva Guduru, PhD
Postdoc
shivag@email.unc.edu
Megan Hopkins, PhD
Postdoc
mdh1992@email.unc.edu
Deyu Kong, PhD
Postdoc
deyu2@email.unc.edu
Yubai Zhou, PhD
Postdoc
zhouyb@email.unc.edu